The Long Run with Luke Timmerman
Een podcast door Timmerman Report
173 Afleveringen
-
Ep115: Rahul Singhvi on Reimagining Biotech Manufacturing
Gepubliceerd: 7-6-2022 -
Ep114: Chris Gibson on Industrializing Drug Discovery
Gepubliceerd: 23-5-2022 -
Ep113: Lewis Cantley & Siddhartha Mukherjee on Fighting Cancer with Food and Drugs
Gepubliceerd: 9-5-2022 -
Ep112: Bernat Olle on Microbiome Therapeutics
Gepubliceerd: 18-4-2022 -
Ep111: Ray Stevens on Structural Biology-Driven Drug Discovery
Gepubliceerd: 14-3-2022 -
Ep110: Michele Andrasik on Making Clinical Trials More Diverse
Gepubliceerd: 1-3-2022 -
Ep109: Derrell Porter on Cell Therapy Commercialization
Gepubliceerd: 15-2-2022 -
Ep108: Praveen Tipirneni on Targeting Integrins With Small Molecules
Gepubliceerd: 31-1-2022 -
Ep107: Bassil Dahiyat on Antibody Engineering & Company Building
Gepubliceerd: 11-1-2022 -
Ep106: Vineeta Agarwala on Health Data & VC Investing
Gepubliceerd: 20-12-2021 -
Ep105: Nello Mainolfi on Targeted Protein Degraders
Gepubliceerd: 6-12-2021 -
Ep104: Jeff Bluestone on Treg Cell Therapies for Autoimmunity
Gepubliceerd: 1-12-2021 -
Ep103: Ken Song on Targeted Radiopharmaceuticals for Cancer
Gepubliceerd: 23-11-2021 -
Ep102: David Baltimore Reflects on a Life in Science
Gepubliceerd: 8-11-2021 -
Ep101: Tony Kulesa on Fostering Founder-Led Biotechs
Gepubliceerd: 26-10-2021 -
Ep100: Christian Henry on Long Read DNA Sequencing
Gepubliceerd: 13-10-2021 -
Ep99: Keolu Fox on Genome Sequencing of Indigenous Populations
Gepubliceerd: 27-9-2021 -
Ep98: Mara Aspinall on Diagnostics and COVID-19
Gepubliceerd: 13-9-2021 -
Ep97: John Evans on Base Edited Therapeutics
Gepubliceerd: 7-9-2021 -
Ep96: Julie Grant and Sam Blackman on Cancer Drugs for Kids
Gepubliceerd: 9-8-2021
"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.
